Joie Krintzman is used to being in a dance store. In her youth, she took up competitive dance, an art she kept going through high school. Now, her two daughters have now followed suit, with her eldest starting at the age of 6. “Her favorite thing to do was to go inside the dance shop. Read More →
California Gov. Gavin Newsom and other elected officials were in Santa Barbara to support work underway that has made a difference following Jan. 9’s unprecedented storm and express the need to locals to stay vigilant as more rainfall is expected. Newsom, Rep. Salud Carbajal, Senators Monique Limon and Gregg Hart and other local officials were Read More →
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Goleta-based Jordano’s Foodservice, a family-owned broad line foodservice distributor, announced Jan. 11 that the company has increased its cooler distribution center. With the additional 27,000 square feet of cooler space, Jordano’s will be adding — bringing its total to nearly 140,000 square feet — the company will be expanding its presence in the region for Read More →
Update: As of Jan. 12, no county in California is designated as an extreme drought area while locations that were in severe drought are down from 71% to 46%. Another storm has come and gone along the Central Coast — though another could be approaching soon — and luckily it seems the area has largely Read More →
Acelyrin, a Los Angeles-based biotechnology company, announced its first acquisition of ValenzaBio, a privately held company developing therapies for autoimmune and inflammatory diseases, in an all-stock transaction, the company said Jan. 5. With the acquisition, Acelyrin gains multiple clinical and pre-clinical development programs to its robust immunology pipeline, which is led by izokibep, a small Read More →